Medtronic PLC (MDT) stock analysis and fair value
MDT · NYSE · Healthcare
88,48 US$
▲ +0,83%
In 30 seconds
The business. Healthcare. Sells 36,4 B US$ a year, keeps 13% as profit and sales grow 3,8% a year (last 5 years).
The price. At its usual price: you pay 24x earnings, close to its normal (25x).
Strength. Passes 5 of 8 quality checks, but debt weighs: 3,8 years of profit.
MDT fair value
Work out what the stock is worth with your own growth, margin and return assumptions. Free during launch.
See the fair valueMedtronic PLC key numbers
- Market cap
- 113,3 B US$
- P/E (price ÷ earnings)
- 23,7
- Dividend yield
- 3,21%
- Revenue growth
- 2,3%
- a year, over 9 years
- Profit margin
- 13,2%
- Quality checks
- 5/8
Fiscal 2026 financials, as filed with the SEC.
What analysts say
Buy
23 of 34 analysts recommend buying.
See everything about MDT on Cerne
- Fair value with your own assumptions
- Every analyst and price target
- 10 years of financials in simple charts
- Dividends, earnings and ratios vs. the sector